Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

NANOCO GROUP PLC Director's Dealing 2015

Oct 14, 2015

4931_dirs_2015-10-14_4a81b7d5-5144-4fd7-9e45-e7d6082a9027.html

Director's Dealing

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 2756C

Nanoco Group PLC

14 October 2015

For immediate release 14 October 2015

NANOCO GROUP PLC

("Nanoco" or the "Company") 

Director Share Purchase

Nanoco Group plc (LSE: NANO), a world leader in the development and manufacture of cadmium-free quantum dots and other nanomaterials, was notified on 14 October 2015 that David Blain, the Company's Chief Financial Officer, had purchased 14,700 ordinary shares of 10p each in the Company ("Ordinary Shares") on 14 October 2015 at an average price of 57.97p per Ordinary Share.

The Ordinary Shares are held by Blain Associates Limited, a company of which David Blain is the sole shareholder.

Following this transaction, David Blain has a beneficial interest in 14,700 Ordinary Shares, representing approximately 0.006% of the Company's issued share capital.

For further information, please contact:

Nanoco Tel: +44 (0) 161 603 7900
Michael Edelman, Chief Executive Officer
David Blain, Chief Financial Officer
Canaccord Genuity - Joint Broker Tel: +44 (0) 20 7523 8000
Simon Bridges

Cameron Duncan
Mark Whitmore
Liberum - Joint Broker Tel: +44 (0) 20 3100 2000
Neil Patel
Richard Bootle

Steven Tredget
Buchanan Tel: +44 (0) 20 7466 5000
Mark Court / Sophie Cowles / Stephanie Watson

Notes for editors:

About Nanoco Group plc

Nanoco is a world leader in the development and production of cadmium-free quantum dots and other nano-materials for use in multiple applications including LCD displays, lighting, solar cells and bio-imaging. In the display market, it has an exclusive manufacturing and marketing licensing agreement with The Dow Chemical Company.

Nanoco was founded in 2001 and is headquartered in Manchester, UK. It has production facilities in Runcorn, UK, and a US subsidiary, Nanoco Inc, based in Concord, MA. Nanoco also has business development executives in Japan, Korea and Taiwan. Its technology is protected worldwide by a large and growing patent estate.

Nanoco is listed on the main market of the London Stock Exchange and trades under the ticker symbol NANO. For further information please visit: www.nanocogroup.com.

This information is provided by RNS

The company news service from the London Stock Exchange

END

RDSEADELFDLSFFF